July 14, 2022
OSE Immunotherapeutics Appoints Alexis Vandier as Chief Executive Officer
NANTES, France, July 13, 2022 (GLOBE NEWSWIRE) — OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) is pleased to announce the…
Pharmaceuticals, Biotechnology and Life Sciences
NANTES, France, July 13, 2022 (GLOBE NEWSWIRE) — OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) is pleased to announce the…
RESEARCH TRIANGLE PARK, N.C., July 13, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today…
The trial is single center, prospective study collecting coincident samples of oral fluids and blood to evaluate the time-course of…
Technology is awarded for its innovation to treat depression with NeuroStar Advanced Therapy for Mental HealthMALVERN, Pa., July 13, 2022…
LAS VEGAS, July 13, 2022 (GLOBE NEWSWIRE) — Healthy Extracts’ (OTCQB: HYEX) reported record preliminary unaudited results for the second quarter…
VANCOUVER, Washington, July 13, 2022 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing…
ANAHEIM, CA, July 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and…
FREMONT, CA, July 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical…
SOUTH SAN FRANCISCO, Calif., July 13, 2022 (GLOBE NEWSWIRE) — The GBT Foundation, a 501(c)(3) organization primarily funded by Global Blood…
ILUVIEN® data to be presented onsite at the annual American Society of Retina Specialists (ASRS) conference.ATLANTA, July 13, 2022 (GLOBE…